8,517 articles
Jacques J. Bourgoignie
Jacques J. Bourgoignie is an American nephrologist at Washington University, Albert Einstein, and the University of Miami, known for his 1988 New England Journal of Medicine study linking cocaine to rhabdomyolysis.
Jacques Oudin
Jacques Oudin (1908–1985) was a French physician and immunologist at the Institut Pasteur who developed immunodiffusion in gels and discovered allotypy and idiotypy in antibodies.
Jacques Van Dam
Jacques Van Dam (J. Van Dam) is a gastroenterologist who led Stanford's gastroenterology division until 2021 and served as president of the American Society for Gastrointestinal Endoscopy.
Jadwiga A. Wedzicha
Jadwiga A. Wedzicha, born 1953, is a British respiratory physician and professor at Imperial College London known for research on COPD exacerbations and for leading the FLAME trial.
Jae Hyung Park
Jae Hyung Park (박재형) is a South Korean chemical engineer and nanomedicine researcher, a professor at Sungkyunkwan University since 2011 known for polymeric nanomedicine, cancer immunotherapy, and extracellular vesicles.
Jae K. Oh
Jae K. Oh, also known as Jae Oh, is a Korean-born cardiologist at Mayo Clinic in Rochester, Minnesota, known for echocardiography and the CoreValve TAVR trial imaging analyses.
Jae U. Jung
Jae U. Jung, also known as Jae Jung, is a virologist and cancer biologist who studies Kaposi's sarcoma-associated herpesvirus and chairs Cancer Biology at Cleveland Clinic.
Jaffer A. Ajani
Jaffer A. Ajani is a gastrointestinal medical oncologist and tenured professor at MD Anderson Cancer Center who has chaired the NCCN esophageal and gastric cancers panel since 1997.
Jagat Narula
Jagat Narula is an Indian-American cardiologist known for imaging vulnerable heart plaques and describing apoptosis in heart failure, and president of the World Heart Federation since 2025.
Jaideep Bains
Jaideep S. Bains is a Canadian neuroscientist known for showing that stress can be transmitted socially through alarm signals, and who has led the Krembil Research Institute in Toronto since 2022.
Jaime Bosch (hepatologist)
Jaime Bosch (Jaume Bosch Genover, 1947–2025) was a Spanish hepatologist at the University of Barcelona and Hospital Clínic known for research on portal hypertension and the early-TIPS trial.
Jaime Grutzendler
Jaime Grutzendler is a Colombian-born neurologist and neuroscientist at Yale School of Medicine who studies stroke and neurodegeneration, known for intravital imaging of living brain cells and the 2010 embolus extravasation mechanism.
Jaime Sepulveda Amor
Jaime Sepúlveda Amor is a Mexican epidemiologist and global health leader who designed Mexico's Universal Vaccination Program, eliminating polio, measles, and diphtheria, and leads UCSF's global health institute.
Jakob Nikolas Kather
Jakob Nikolas Kather, also published as Jakob N. Kather, is a German physician and computer scientist known for predicting cancer molecular features from routine histopathology slides using deep learning.
James A. Berkley
James A. Berkley is a pediatric infectious-diseases physician and Oxford professor based at the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya, since 1997, known for research on bacteremia and severe malnutrition in children.
James A. de Lemos
James A. de Lemos, also published as James de Lemos, is an American cardiologist at UT Southwestern known for biomarker research and the Dallas Heart Study.
James A. DeCaprio
James A. DeCaprio is an American physician-scientist at Dana-Farber Cancer Institute who showed that SV40 large tumor antigen binds the retinoblastoma protein and identified the DREAM complex.
James A. Fagin
James A. Fagin is an Argentine-born American physician-scientist who studies and treats thyroid cancer at Memorial Sloan Kettering Cancer Center, known for restoring radioiodine uptake in refractory tumors.
James A. Halsted
James A. Halsted was an American physician and nutrition researcher who studied vitamin B12 absorption and, during a Fulbright post in Shiraz, Iran, opened the study of human zinc deficiency.
James A. Merchant
James A. Merchant is an American physician and epidemiologist at the University of Iowa whose cotton dust research led to OSHA's 1978 Cotton Dust Standard.
James A. Nathanson
James A. Nathanson is a physician-scientist with MD and PhD degrees known for research on cyclic nucleotide signaling in the brain, cerebral vessels, and eye.
James A. R. Nicoll
James A. R. Nicoll is a British clinical neuropathologist and Professor of Neuropathology at the University of Southampton, known for the first neuropathological study of an Alzheimer brain after amyloid immunization.
James B. Bassingthwaighte
James B. Bassingthwaighte was a Canadian-born cardiovascular physiologist and bioengineer at the University of Washington who modeled blood flow in organs and founded the Physiome Project in 1997.
James B. Meigs
James B. Meigs is an American physician-scientist and genetic epidemiologist at Harvard Medical School and Massachusetts General Hospital who studies the cause and prevention of type 2 diabetes.
James B. Rowe
James B. Rowe is a British neurologist, Professor of Cognitive Neurology at the University of Cambridge, and consultant at Addenbrooke's Hospital who studies Alzheimer's disease, frontotemporal dementia, and PSP.
James B. Seward
James B. Seward is an American cardiologist and echocardiographer who directed Mayo Clinic's Echocardiography Laboratory in Rochester, Minnesota, and helped develop the Tei index and AcuNav catheter.
James Brenton (oncologist)
James D. Brenton is a clinician-scientist and Professor of Ovarian Cancer Medicine at the Cancer Research UK Cambridge Institute, known for blood tests tracking tumor DNA in ovarian cancer.
James Bristow
James Bristow is a physician-scientist in pediatric cardiology and human genetics, a UCSF professor who showed that tenascin-X deficiency causes a recessive form of Ehlers–Danlos syndrome.
James Bruce Bussel
James Bruce Bussel, also known as James B. Bussel, is an American pediatric hematologist at Weill Cornell Medicine who defined the modern treatment of fetal alloimmune thrombocytopenia.
James Brugarolas
James Brugarolas is a kidney cancer physician-scientist and professor at UT Southwestern whose work on HIF-2 led to belzutifan, first FDA-approved HIF-2 inhibitor for kidney cancer.